| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 08-08-2025 | 06-30-2025 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $24 to ...
Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that sho...
Baird analyst Vikram Kesavabhotla initiates coverage on Omada Health (NASDAQ:OMDA) with a Neutral rating and announces Price...
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $27...
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $21 to ...
Needham analyst Ryan MacDonald maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $23 to $24.
Financial OutlookFor the year ending December 31, 2025, Omada expects:Revenue in the range of $235 million to $241 millionAdjus...
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.14...
